For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $0.87 in the prior trading day, Iterum Therapeutics Plc (NASDAQ: ITRM) closed at $0.83, down -4.51%. In other words, the price has decreased by -$4.51 from its previous closing price. On the day, 0.75 million shares were traded. ITRM stock price reached its highest trading level at $0.8753 during the session, while it also had its lowest trading level at $0.8184.
Ratios:
Our goal is to gain a better understanding of ITRM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 2.69.
On March 15, 2021, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $2.50.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on June 02, 2020, whereas the target price for the stock was revised from $7 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’25 when Dunne Michael W. bought 15,000 shares for $0.72 per share. The transaction valued at 10,854 led to the insider holds 235,001 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITRM now has a Market Capitalization of 37100952 and an Enterprise Value of 58383508.
Stock Price History:
The Beta on a monthly basis for ITRM is 3.05, which has changed by -0.36321837 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, ITRM has reached a high of $3.02, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -7.73%, while the 200-Day Moving Average is calculated to be -36.23%.
Shares Statistics:
The stock has traded on average 750.86K shares per day over the past 3-months and 962240 shares per day over the last 10 days, according to various share statistics. A total of 44.66M shares are outstanding, with a floating share count of 43.68M. Insiders hold about 2.19% of the company’s shares, while institutions hold 4.57% stake in the company. Shares short for ITRM as of 1753920000 were 2080639 with a Short Ratio of 2.77, compared to 1751241600 on 1187421. Therefore, it implies a Short% of Shares Outstanding of 2080639 and a Short% of Float of 4.95.
Earnings Estimates
The dynamic stock of Iterum Therapeutics Plc (ITRM) is currently attracting attention from 1.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.01, with high estimates of $0.01 and low estimates of $0.01.
Analysts are recommending an EPS of between -$0.33 and -$0.33 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.09, with 2.0 analysts recommending between $0.1 and -$0.27.
Revenue Estimates
Based on 2 analysts’ estimates, the company’s revenue will be $16.3M in the next fiscal year. The high estimate is $17.5M and the low estimate is $15.1M.
